Drugs / carbidopa/levodopa
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04082715 | Oct 2019 → Dec 2022 | chronic pain syndrome | Second Affiliated Hospital of Wenzhou Medical University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carbidopa/levodopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04082715 ↗ |